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reduced the occurrence of VAs (2.70.48, 2.50.53, 1.70.48 versus 3.30.95)
and ameliorated the shortening of 90% repolarization of action potential durations
(APD90) and the dispersion of APD (APDd) during myocardial ischemia
reperfusion.
Conclusions: Taxol pre-treatment reduces ischemia-related VAs, improved APD90,
preserves normal Cx43 expression and locations during myocardial ischemia. These
ﬁndings provide potential therapeutic targets for ameliorating VAs during IR.
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DPP-4 Inhibitors Repress Foam Cell Formation by Inhibiting Scavenger
Receptors through Protein Kinase C Pathway
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Objectives: studies show that dipeptidyl peptidase-4 (DPP-4) inhibitors may have an
anti-atherosclerotic effect. Since foam cells are key components of atherosclerotic
plaque, we studied the effect of DPP-4 inhibitors on foam cell formation.
Methods: Foam cell formation was studied by treatment of primary and THP-1
macrophages with oxidized low density lipoprotein (ox-LDL) in the absence or
presence of DPP-4 inhibitors (sitagliptin and NVPDPP728). The expression of
scavenger receptors (SR) SRA, CD36 and LOX-1 was measured, and their role in
foam cell formation in the presence of DPP-4 inhibitors was examined by their over-
expression. In additional studies, role of protein kinase (PK) C and A in the effect of
DPP-4 inhibitors was examined.
Results: Foam cell formation was markedly reduced by both DPP-4 inhibitors, as was
the expression of CD36 and LOX-1 (CD36>>LOX-1), but not SRA. Simultaneously,
there was a reduction in phosphorylated-PKC, but not PKA, content. Recovery of
phosphorylated-PKC following treatment of cells with PMA negated the effect of
DPP-4 inhibitors on foam cell formation. Further, over-expression of CD36 or LOX-1
blocked the effect of DPP-4 inhibitors on foam cell formation.
Conclusions: DPP-4 inhibitor exerts a potent inhibitory effect on foam cell formation
from human macrophage cell line in response to ox-LDL. This effect is primarily
mediated by decrease in the expression of two different SRs on monocytes/macro-
phages CD36 and LOX-1. This results in a decrease in ox-LDL internalization. DPP-4
inhibitors also exert a potent inhibitor effect on PKC activation, perhaps mediated by
membrane-bound DPP-4, which plays a critical role in foam cell formation, inﬂam-
mation and atherogenesis.
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Objectives: To investigate the association between suppressor of cytokine signaling 3
(SOCS3) genetic polymorphisms and insulin resistance (IR) inXinjiangUygur population.
Methods: In this cross-sectional study on the metabolic diseases (e.g. obesity) among
Uygur Chinese in Hetian, Xinjiang China,1292 Uygur individuals were enrolled. The
sample size for IR subjects [homeostasis model assessment for insulin resistance
(HOMA-IR) 2.96] was 323, whereas that for non-IR controls was 969 (HOMA-
IR<2.96). Representative variations were selected according to gene database and
genotyping using the TaqMan polymerase chain reaction method in 1292 Uygur in-
dividuals. A relatively isolated general population in a relatively homogeneous
environment and a case-control study was conducted to test the association between
the genetic variations of SOCS3 gene and insulin resistance.
Results: There was signiﬁcant difference of genotype distribution of rs4969168
between insulin resistance and control groups in the male population (P¼0.027).
Although the insulin resistance related quantitative phenotypes have no signiﬁcantly
difference in individuals with GG AG and AA genotypes of rs4969168 in total, male
and female population (P>0.05) the mean of body mass index and the median of
fasting insulin increased in individuals with GG AG AA genotypes of rs4969168 in
male population. But not in total and female population. Haplotype 2 (rs12953258C-
rs4969168A-rs9914220C) was signiﬁcantly associated with a higher prevalence of IR
in male population (P¼0.023). The logistic regression analysis showed that AG ge-
notype of rs4969168 variation might be a protective factor for insulin resistance in
male (OR¼0.564, 95% conﬁdence interval 0.344-0.925. P¼0.023).
Conclusions: The present study suggests that the rs4969168 polymorphism in SOCS3
gene may be associated with insulin resistance in Xinjiang Uygur men.
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Cardioprotective effect of sCR1 on myocardial ischemia-reperfusion
injury in Rats
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Medical University, Chongqing, People’s Republic of ChinaJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BObjectives: The aim of this study was to investigate the effects of soluble complement
receptor 1 (sCR1) on rat models of myocardial I/R, explore its potential mechanisms
of cardioprotection.
Methods: Myocardial ischemia-reperfusion model was built, randomly assigned to
sham operation group (SOG) and ischemia reperfusion group (IRG) and sCR1 pre-
treatment group (CPG). Observation on myocardial infarct size and microstructure of
each group, using RT-PCR and Elisa to detect expression of LC3-II and Beclin1
mRNA and protein.
Results: Compared with IRG, myocardial infarct size and microstructure damage are
reduced in CPG. The mRNA and protein of Beclin1 and LC3-II were detected in each
group of Myocardial, while in CPG increased than IRG.
Conclusions: sCR1 could protect myocardial ischemia-reperfusion injury, may be
associated with fading excessive autophagy in myocardiac.
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Objectives: To investigate the effects of salvianolic acid on the proliferation, adhesion
and nitric oxide (NO) secretion activity of endothelial progenitor cells (EPCs) cultured
in vitro.
Methods: The mononuclear cells (MNCs) were isolated from human peripheral blood
by Ficoll density gradient centrifugation, and then the cells were planted on the human
ﬁbronectin (FN) coated culture dishes. The cells were suspended in endothelial basal
medium (EBM-2) supplemented with EGM-2-MV-SingleQuots. EPCs were charac-
terized as adherent cells double positive for DiL-acLDL uptake and lectin binding by
direct ﬂuorescent staining under a laser scanning confocal microscope. After cultered
for 7 days, EPCs were randomized into 6 groups: control group, simvastatin group and
different concentrations of salvianolic acid groups (0.5, 2.5, 5,10mg/L). After different
periods of culturing (24h,48h,72h) the ability of cell proliferation was assayed with
MTT assay, counting adherent cells assayed the adhesion activity of EPCs, the NO
content was measured in the cell culture medium by nitrate reductase method to ﬁnd
the effect on cell secretion activity.
Results: Incubation of EPCs with Salvianolic acid increased the number of EPCs,
with a maximum at 5mg/L after 24 hours (P<0.01). In addition, Salvianolic acid
promotes EPCs proliferative, adhesive and NO secreting capacity.
Conclusions: Salvianolic acid can promote EPCs augmentation and enhance its
proliferation, adhension and NO secreting function. It is likely to be a new mechanism
of EPCs for therapy ischemic disease.
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Objectives: The purpose of this study was to investigate the role of small interference
RNA (siRNA) on expression of E637K-hERG (human ether-a-go-go-related gene)
mutant and whether it can be used to rescue the mutant’s dominant-negative sup-
pressive effects on hERG protein channel function.
Methods: Western blot was performed to select the most sensitive siRNs to target
E637K-hERG mutant knockdown. Confocal laser scanning microscope was per-
formed to monitor cellular localization of wild-type (WT) -hERGandE637K-hERG
with or without siRNA. Patch-clamp technique was used to assess the effect of siRNA
on the electrophysiologic characteristics of the rapidly activating delayed rectiﬁer K+
current IKr of the hERG protein channel.
Results: siRNA led to a signiﬁcant decrease in the level of E637K- hERGprotein but did
not affect the level of WT-hERG protein. WT-hERG localization in cells coexpressing
E637K-hERG mutant was restored to the membrane by siRNA. The siRNA-mediated
inhibition of E637K-hERG mutant restored the maximum current and tail current am-
plitudes. Furthermore, siRNA treatment rescued the kinetic properties of WT/E637K-
hERG protein channel to a level comparable to that of WT-hERG protein channel.
Conclusions: Our ﬁndings illustrated that siRNA can effectively inhibit E637K-
hERG protein expression and rescue the dominant- negative effect of this mutation by
restoring the kinetic properties of hERG protein channel. It has potential clinical
implications with regard to the possibility of using siRNA in the treatment of LQTS.
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Objectives: The main aim of this study was to systematically evaluate the expression
patterns of the Nestin in the developing or damaged adult heart issue, and probe into
whether Nestin can be as a marker of cardiac stem cell.
Methods: Nestin expression was assessed in the embryonic 13.5 d and postnatal 1d,
7d, 1M, 3M old Nestin-GFP transgenic mouse heart tissue by ﬂuorescence micro-
scopy, real-time quantitative PCR and RT-PCR. Myocardial infaction model was
established by ligation of left anterior descending coronary in adult Nestin-GFP mice
and the Nestin expression was observed in the myocardium at 7d after injury. Then,
the correlation between Nestin and other stem cell markers’ expression in mouse heart
tissue were determined by immunoﬂuoresent assay.
Results: In embryonic 13.5 d, the Nestin mainly expressed in the brain, spinal cord
and the retina, and also can be observed in the heart tissue. After the mouse was born,
Nestin expression is gradually reduced with growth, and that was also conﬁrmed by
the RT-PCR, Q-PCR analysis. Nestin-positive cells increased signiﬁcantly in
myocardial infarction area compared to the normal tissue. Sca-1, c-kit, Isl-1 and
Nkx2.5 are widely expressed in heart tissue, but not co-expressed with Nestin.
However, in normal and injured tissue, Nestin was co-expressed with vimentin and
musashi-1, neural cell marker.
Conclusions: These results indicate that nestin expression is highly correlated with
cardiac development, and the Nestin-positive myocardial cell might be arise from
neural linage cells, which suggest that such cells play an important role in the growth
and maintenance of the cardiogenesis and regeneration.
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Objectives: To develop a bama miniature pig intimal hyperplasia model in superﬁcial
femoral artery.
Methods: Following 1 month of a 3% cholesterol diet, 4 pigs underwent surgical
perfusion with distilled water (n¼8). 3 pigs were subjected to sham-operation for
control (n¼6). After 3 months of the same diet, sonography and histologic sections of
the vessels were analyzed.
Results: Intimal hyperplasia was conﬁrmed in experimental group (8 of 8), whereas
the control group remained intact. Lumen area was drastically decreased as assessed
by sonography. Histologic sections showed that arteries of experimental group had a
increased intimal areas (0.420.03 mm2), increased intimal area/Media area ratios
(0.50.12 mm2) and decreased lumen areas (0.350.05 mm2 vs 0.620.03
mm2,P<0.05).
Conclusions: This novel intimal hyperplasia model may be a useful tool for evalu-
ating drugs and therapeutic devices.
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Calreticulin is localized in the mitochondria of rat cardiomyocytes and affected
by furazolidone
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Objectives: Calreticulin is a calcium-buffering protein which is predominately located
in endoplasmic reticulum. We have previously shown calreticulin is also localized in
the myocardial mitochondria and up-regulated in a rat model of furazolidone-induced
dilated cardiomyopathy. The aim of this study was to determine whether calreticulin is
localized in the mitochondria of rat cardiomyocytes and whether mitochondrial cal-
reticulin is affected by furazolidone.
Methods: Themitochondrial preparations were isolated from primary cultured neonatal
rat cardiomyocytes and puriﬁed bydifferential centrifugation. The immunoreactivities of
calreticulin and markers for cytosol, nucleus, endoplasmic reticulum and plasma
membranewere detected bywestern blot. The distribution of calreticulin tomitochondria
was further conﬁrmed by immuno-electron microscopy, ﬂow cytometry and laser
scanning confocal microscopy (double staining with MitoTracker Red and calreticulin).
To studywhether the content of mitochondrial calreticulin was affected by furazolidone,
the rat cardiomyocytes were exposed to 100 mmol/L furazolidone for 48 h and then the
mitochondrial calreticulin expression was analyzed using western blot.
Results: Western blot and immune-electron microscopy showed that calreticulin was
present in the mitochondria of rat cardiomyocytes; moreover, the co-localization of
calreticulin and mitochondria was further conﬁrmed by ﬂow cytometry and laser scan-
ning confocal microscopy. Furazolidone treatment signiﬁcantly increased the content of
mitochondrial calreticulin by 3.70.7 fold (P<0.05) in the rat cardiomyocytes.
Conclusions: In summary, the present results suggest that calreticulin is localized in
the mitochondria of rat cardiomyocytes and such localization is affected by
furazolidone.
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Objectives: Bisphenol A (BPA) is a man-made high volume production chemical and
human is widely-spread exposure to BPA. Previous studies have showed that the BPAC36 JACC Vol 64/16/Suppl C j Octobexposure is associated with heart disease, but the mechanisms of BPA on the heart are
still unclear. The purpose of this research is to investigate the relation between the
concentrations of BPA and severity of the lesions in the heart and analyze the
molecular mechanism of BPA harmful effect.
Methods: Mice were subcutaneously injected with normal saline or 0.1, 1 and
10mg/kg/day BPA for 1 month, and then were detected by Vevo 770 ultrasonic
diagnostic apparatus, respectively. The cardiomyocytes were isolated from neonatal
rats and were treated by PBS or 0.1, 1 and 10uM BPA. The protein of gH2AX was
detected by western blot. The mRNA level and the protein level of P21 were tested by
real-time PCR and western blot. The protein maps of the cardiomyocytes stimulated
by PBS or BPA were measured by two-dimensional gel electrophoresis and the dif-
ferential protein spots were identiﬁed by mass spectrometry.
Results: EF value and FS value were signiﬁcantly decreased in 1 and 10mg/kg/day
BPA groups comparing with normal saline group, and BPA produced a dose-
dependent reduction in EF and FS value. The expression of gH2AX and P21 were
obviously increased with the concentration of BPA in a dose-dependent manner. Some
differentially expressed proteins were determined to be the signal transduction asso-
ciated proteins of DNA damage.
Conclusions: This study mainly reveals that BPA is harmful to the heart and
cardiomyocytes. Its mechanism may be that BPA causes DNA damage in cardiac
muscle cell.
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Objectives: To detect the effect of hepatocyte growth factor (HGF) on xanthine
oxidase (XO) under hypoxia/reoxygenation (H/R) conditions in rat cardiac micro-
vascular endothelia cells (CMECs).
Methods: Primary cultured rat cardiac microvascular endothelia cells (CMECs) were
exposed to 4h of hypoxia and followed by 1h of reoxygenation. Generation of ROS
and cytosolic Ca2+ concentration was measured by ﬂow cytometry qualiﬁcation of
DCFH-DA and ﬂuo-3 AM staining cells, respectively. XDH mRNA was qualiﬁed by
RT-PCR analysis. XO activity was determined by colorimetric assay and XO protein
levels were determined by Western blot.
Results: After hypoxia/reoxygenation (H/R), cellular ROS production signiﬁcantly
increased. Both XO activity and XO protein increased after H/R. Cellular ROS
elevation were inhibited by allopurinol (a potent XO inhibitor), indicting XO
accounting for the generation of ROS after H/R. In addition, XDH mRNA increased
after H/R, indicating a de novo XDH synthesize, which need to be converted to XO to
become a source of superoxide. Pretreatment of HGF inhibited the elevation of XO
activity and XO protein level after H/R; however, HGF has no effect on the increase of
XDH mRNA. It has been reported that Ca2+ acts in regulating the post-transcripitional
conversion from XDH to XO, and we also ﬁnd an increase of the cytosolic Ca2+ in
CMECs after H/R. BAPTA-AM, a cell-permeable Ca2+ chelator, prevented the in-
crease of XO activity and XO protein levels, implicating the elevated cytosolic Ca2+
concentration involvement in XO conversion and XO activation. Furthermore, HGF
inhibited the elevation of cytosolic Ca2+ concentration in CMECs after H/R. Thus,
HGF inhibited XO activation and XO protein production after H/R by blocking the
elevation of cytosolic Ca2+ concentration in CMECs.
Conclusions: These ﬁndings suggest a novel mechanism whereby HGF inhibited
XO-generated ROS production after H/R treatment. H/R induces a de novo synthesize
of XDH, the XO precursor. In addition, H/R increases cytosolic Ca2+ concentration
and promotes a Ca2+ -involved XO conversion and XO activation. HGF has no effect
on the increase of XDH mRNA; however HGF inhibited the elevation of XO protein
level and XO activity after H/R in the post-transcriptional level primarily by inhibiting
the increase of cytosolic Ca2+ concentration.
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Knock-down of metallothionein exacerbates intermittent hypoxia induced
oxidative and inﬂammatory injury in aorta
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Objectives: Obstructive sleep apnea (OSA) is an independent risk factor for cardio-
vascular diseases possibly via intermittent hypoxia (IH) - elicited oxidative stress and
inﬂammation, while metallothionein (MT) has been recognized as an inducible anti-
oxidant which may protect against damages from a variety of oxidative stimuli. The
present study was to explore the effect of MT on IH-induced aortic pathogenic
changes.
Methods: To mimic hypoxia/reoxygenation events that occur in adult OSA patients,
mice were exposed to IH for up to 8 weeks. The IH paradigm consisted of alternating
cycles of 20.9% O2 /8% O2 FIO2 (30 episodes per hour) with 20 seconds at the nadir
FIO2 for 12 hours a day during the light phase. Markers of oxidative damages,
inﬂammation, and vascular remodeling were observed by immunohistochemical
staining after 3 days, 1, 3 and 8 weeks after IH exposures.
Results: Endogenous MT was induced after 3 days of IH, but was signiﬁcantly
decreased after 8 weeks of IH. Compared with the wild-type mice, MT knock-out
mice exhibited earlier and more severe pathogenic changes of oxidative damages,
inﬂammatory responses and cellular apoptosis, as indicated by the signiﬁcanter 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
